Literature DB >> 3240769

Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle.

H Karaki1, K Sato, H Ozaki, K Murakami.   

Abstract

The inhibitory effect of sodium nitroprusside on the cytosolic Ca2+ level ([Ca2+]cyt), measured simultaneously with contraction by means of a fluorescence dye, fura-2, and on the 45Ca2+ uptake was tested in the isolated rat aortic smooth muscle. Norepinephrine increased muscle tension, 45Ca2+ uptake and [Ca2+]cyt. In a Ca2+-deficient solution, norepinephrine transiently increased muscle tension and [Ca2+]cyt. Sodium nitroprusside inhibited all changes induced by norepinephrine although the inhibition of [Ca2+]cyt was less than that of muscle contraction. Sodium nitroprusside also inhibited the high K+-induced contraction at concentrations higher than those needed to inhibit norepinephrine-induced contraction. Inhibition of the high K+induced contraction was accompanied by a small decrease in [Ca2+]cyt and a smaller decrease in 45Ca2+ uptake. Methylene blue antagonized, and M&B 22,948 potentiated the inhibitory effect of sodium nitroprusside. These results suggest that sodium nitroprusside has multiple sites of action. At relatively low concentrations, sodium nitroprusside could inhibit the Ca2+ influx and Ca2+ release. At relatively high concentrations, this inhibitor could also augment Ca2+ sequestration and decrease the sensitivity of contractile elements to Ca2+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3240769     DOI: 10.1016/0014-2999(88)90329-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  Effects of endothelin on the mechanical activity and cytosolic calcium level of various types of smooth muscle.

Authors:  K Sakata; H Ozaki; S C Kwon; H Karaki
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Inhibitory effect of a toxin okadaic acid, isolated from the black sponge on smooth muscle and platelets.

Authors:  H Karaki; M Mitsui; H Nagase; H Ozaki; S Shibata; D Uemura
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Force and intracellular Ca2+ during cyclic nucleotide-mediated relaxation of rat anococcygeus muscle and the effects of cyclopiazonic acid.

Authors:  G L Raymond; I R Wendt
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Action of a NO donor on the excitation-contraction pathway activated by noradrenaline in rat superior mesenteric artery.

Authors:  P Ghisdal; J P Gomez; N Morel
Journal:  J Physiol       Date:  2000-01-01       Impact factor: 5.182

5.  The role of intracellular calcium stores in motilin induced contractions of the longitudinal muscle of the rabbit duodenum.

Authors:  G Matthijs; T L Peeters; G Vantrappen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

6.  Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2.

Authors:  T Yanagisawa; M Kawada; N Taira
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Maxi K+ channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells.

Authors:  J Taniguchi; K I Furukawa; M Shigekawa
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

8.  Effects of 8-bromo cyclic GMP and verapamil on depolarization-evoked Ca2+ signal and contraction in rat aorta.

Authors:  S Salomone; N Morel; T Godfraind
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells.

Authors:  J W Assender; K M Southgate; M B Hallett; A C Newby
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells.

Authors:  T Imai; Y Hirata; K Kanno; F Marumo
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.